Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.

Takashi Yamamura, Naoyuki Matsumoto, Yasuyoshi Matsue, Michisato Okudera, Youichi Nishikawa, Yoshimitsu Abiko, Kazuo Komiyama

PubMed · 2014 · 21 citations · 38 references

Abstract

SB inhibits expression of lymphangiogenic factors in HSC-3 cells. Within the limitations of the present study, SB may have potential as an anti-metastatic pro-drug for oral cancer.

References

38